Auris Medical Holding AG (EARS)

0.5431 -0.0768 (-12.389%)

IEX Real-Time Price

November 16, 2018 EST.

NASDAQ Capital Market : Healthcare

Prev Close 0.6199

Price Open 0.611

Volume: 2.53M

Avg Volume: 11.47M

Market Cap: 16.08M

P/E Ratio -

52 Wk Range 0.23-9.5



EARS Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2018-10-15
24.07M
2.94M
0.28
12.23%

2018-09-28
24.07M
1.07M
0.34
4.43%

2018-09-14
6.12M
1.76M
0.70
28.81%

2018-08-31
6.12M
486,207
0.46
7.95%




EARS Earning Report


Report Date
Fiscal Period
Announce Time
Estimated EPS(#)
Actual EPS
Surprise Dollar

2018-03-27
Q4 2017
N/A
0.00 (0)
0.00
0.00

2018-03-22
Q4 2017
N/A
0.00 (0)
-1.01
0.00

2018-03-20
Q4 2017
N/A
0.00 (0)
0.00
0.00

2018-03-13
Q4 2017
N/A
0.00 (0)
0.00
0.00

News

Auris Medical Holding (EARS) CEO Thomas Meyer on Q3 2018 Results - Earnings Call Transcript (2018-11-15 11:06 SeekingAlpha)

Auris Medical Holding (EARS) Q3 2018 Results Earnings Conference Call November 15, 2018, 08:00 AM ET Executives Hernan Levett - Chief Financial Officer Thomas Meyer - Chairman and Chief Executive Officer Analysts James Malloy - AGP Briana Warschun - Edison Group Presenta…

 

Auris Medical Holding 2018 Q3 - Results - Earnings Call Slides (2018-11-15 08:03 SeekingAlpha)

The following slide deck was published by Auris Medical Holding in conjunction with their 2018 Q3 earnings Read more …

 

Auris Medical reports Q3 results (2018-11-15 06:47 SeekingAlpha)

Auris Medical (NASDAQ: EARS ): Q3 GAAP EPS of -CHF0.14. More news on: Auris Medical Holding, Earnings news and commentary, Healthcare stocks news, , Read more …

 


Statistics

Shares Outstanding: 29.61M

Top 15 Institution Percent: 37.20

Price To Sales: N/A

Price To Book: 6.52

Revenue: N/A

Gross Profit: N/A

Cash: N/A

Debt: N/A

Return On Assets: -82.24

Return On Equity: -1564.98

Profit Margin: N/A

Price History

Beta: -1.08

50-day Moving Avg: 0.61

200-day Moving Avg: 1.13

YTD Change: -91.24

5-day Change: -18.79

1-month Change: -53.58

3-month Change: 122.04

6-month Change: -63.05

1-year Change: -93.27

Revenue Per Share: 0.00

Revenue Per Employee: 0.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: Auris Medical Holding AG

Exchange: NASDAQ Capital Market

Industry: Biotechnology

Sector: Healthcare

Website: http://www.aurismedical.com

Auris Medical Holding AG is a clinical-stage biopharmaceutical company. It is engaged in the development of novel products for the treatment of inner ear disorders. Its product candidate is AM-101.